116 results
6-K
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
of registrant’s name into English)
Dept 920a 196 High Road, Wood Green,
London, United Kingdom, N22 8HH
(Address of principal executive office)
Indicate … Road, Wood Green, London, United Kingdom, N22 8HH (for documents filed with or furnished to the SEC by the Company).
SIGNATURES
Pursuant
6-K
AMYT
Amryt Pharma Plc
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
into English)
Dept 920a 196 High Road, Wood Green,London, United Kingdom, N22 8HH(Address of principal executive office)
Indicate by check mark whether
6-K
AMYT
Amryt Pharma Plc
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
name into English)
Dept 920a 196 High Road, Wood Green,London, United Kingdom, N22 8HH(Address of principal executive office)
Indicate by check mark
6-K
AMYT
Amryt Pharma Plc
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
name into English)
Dept 920a 196 High Road, Wood Green,London, United Kingdom, N22 8HH(Address of principal executive office)
Indicate by check mark
6-K
AMYT
Amryt Pharma Plc
19 Oct 20
Current report (foreign)
8:00am
of registrant's name into English)
Dept 920a 196 High Road, Wood Green,London, United Kingdom, N22 8HH(Address of principal executive office)
Indicate by check
6-K
67593yadmd nyvb399su
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
2n6noikptkj
31 Mar 22
Results of General Meeting
8:41am
6-K
sz0iy0rbvorpav6hmjcm
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
6-K
6zdb otp0m
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am
6-K
7bazhk7c nwg
31 Jan 22
Current report (foreign)
7:32am
6-K
7j2gkbffw1o8xz
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
6-K
2k7l1 o6n34ydm
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
09l 0shzkos
23 Nov 21
Amryt Provides Update on Regulatory Review Process for Oleogel-S1
8:04am
6-K
hvy43tnip 2lt
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
23vf2jj1el kuql0lhk5
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
6-K
3p11gyshu77gp0iwui
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
6-K
wv0aivjbwy
11 May 22
Current report (foreign)
4:30pm
UPLOAD
4kkx4epew0ypbxd
18 May 22
Letter from SEC
12:00am
6-K
klcwxfw5i4 522nzj4
23 Aug 21
Options Granted to Non-Executive Directors
8:16am
6-K
s72smgp
15 Sep 20
Current report (foreign)
8:31am